What is the prevalence of Familial Hypercholesterolemia?

Familial Hypercholesterolemia is a genetic condition affecting approximately 1 in 200 to 1 in 250 people worldwide, making it a common genetic disorder rather than a rare one. Despite this prevalence, Familial Hypercholesterolemia remains significantly underdiagnosed, with fewer than 10% of affected individuals estimated to be aware of their diagnosis.

What is the global prevalence of Familial Hypercholesterolemia?

While often categorized alongside rare diseases due to its genetic nature, Familial Hypercholesterolemia is relatively common. Epidemiological data from the FH Foundation and the World Health Organization suggest a prevalence of approximately 1 in 250 for the heterozygous form. The homozygous form of Familial Hypercholesterolemia is much rarer, estimated at approximately 1 in 250,000 to 1 in 1,000,000, though these numbers vary by region and founder effect populations.

Are there demographic or geographic variations?

Familial Hypercholesterolemia affects males and females equally, as it is typically inherited in an autosomal dominant pattern. However, the age of onset for clinical complications, such as premature coronary artery disease, may appear earlier in males. Prevalence is notably higher in specific populations due to "founder effects," including:

• Afrikaner populations in South Africa


• Christian Lebanese populations


• French Canadians


• Ashkenazi Jewish populations

Why is accurate data collection challenging?

The primary challenge in tracking Familial Hypercholesterolemia is profound underdiagnosis. Because the condition is "silent" until a cardiovascular event occurs, many people remain undiagnosed until adulthood. Current registry data, including the 14 members currently connected through the DiseaseMaps.org community, highlight the vital importance of family screening to identify "hidden" cases and improve early intervention rates.

Next steps

• Consult a lipidologist or a cardiologist to discuss genetic testing and screening.


• Screen first-degree family members if a diagnosis of Familial Hypercholesterolemia is confirmed.


• Join the DiseaseMaps.org community to share experiences with others living with this condition.


• Maintain a detailed family history of premature heart disease to assist your clinical team.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• Orphanet: Familial hypercholesterolemia (ORPHA:79619).


• NIH Genetic and Rare Diseases Information Center (GARD): Familial Hypercholesterolemia.


• The FH Foundation: Prevalence and Global Burden of Familial Hypercholesterolemia.


• OMIM (Online Mendelian Inheritance in Man): Hypercholesterolemia, Familial (143890).